These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 29169385)

  • 1. Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
    Cho Y; Sautenet B; Rangan G; Craig JC; Ong ACM; Chapman A; Ahn C; Chen D; Coolican H; Kao JT; Gansevoort R; Perrone R; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Gutman T; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Hamiwka LA; Tong A
    Trials; 2017 Nov; 18(1):560. PubMed ID: 29169385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
    Cho Y; Tong A; Craig JC; Mustafa RA; Chapman A; Perrone RD; Ahn C; Fowler K; Torres V; Gansevoort RT; Ong ACM; Coolican H; Tze-Wah Kao J; Harris T; Gutman T; Shen JI; Viecelli AK; Johnson DW; Au E; El-Damanawi R; Logeman C; Ju A; Manera KE; Chonchol M; Odland D; Baron D; Pei Y; Sautenet B; Rastogi A; Sharma A; Rangan G;
    Am J Kidney Dis; 2021 Feb; 77(2):255-263. PubMed ID: 32771648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease.
    Tong A; Samuel S; Zappitelli M; Dart A; Furth S; Eddy A; Groothoff J; Webb NJ; Yap HK; Bockenhauer D; Sinha A; Alexander SI; Goldstein SL; Gipson DS; Hanson CS; Evangelidis N; Crowe S; Harris T; Hemmelgarn BR; Manns B; Gill J; Tugwell P; Van Biesen W; Wheeler DC; Winkelmayer WC; Craig JC;
    Trials; 2016 Aug; 17():401. PubMed ID: 27519274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardised outcomes in nephrology - Haemodialysis (SONG-HD): study protocol for establishing a core outcome set in haemodialysis.
    Tong A; Manns B; Hemmelgarn B; Wheeler DC; Tugwell P; Winkelmayer WC; van Biesen W; Crowe S; Kerr PG; Polkinghorne KR; Howard K; Pollock C; Hawley CM; Johnson DW; McDonald SP; Gallagher MP; Urquhart-Secord R; Craig JC;
    Trials; 2015 Aug; 16():364. PubMed ID: 26285819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy.
    Evangelidis N; Sautenet B; Madero M; Tong A; Ashuntantang G; Sanabria LC; de Boer IH; Fung S; Gallego D; Levey AS; Levin A; Lorca E; Okpechi IG; Rossignol P; Sola L; Usherwood T; Wheeler DC; Cho Y; Howell M; Guha C; Scholes-Robertson N; Widders K; Gonzalez AM; Teixeira-Pinto A; Viecelli AK; Bernier-Jean A; Anumudu S; Dunn L; Wilkie M; Craig JC;
    Trials; 2021 Sep; 22(1):612. PubMed ID: 34503563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
    Cho Y; Rangan G; Logeman C; Ryu H; Sautenet B; Perrone RD; Nadeau-Fredette AC; Mustafa RA; Htay H; Chonchol M; Harris T; Gutman T; Craig JC; Ong ACM; Chapman A; Ahn C; Coolican H; Kao JT; Gansevoort RT; Torres V; Pei Y; Johnson DW; Viecelli AK; Teixeira-Pinto A; Howell M; Ju A; Manera KE; Tong A
    Am J Kidney Dis; 2020 Sep; 76(3):361-373. PubMed ID: 32359822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardized Outcomes in Nephrology-Peritoneal Dialysis (SONG-PD): Study Protocol for Establishing a Core Outcome Set in PD.
    Manera KE; Tong A; Craig JC; Brown EA; Brunier G; Dong J; Dunning T; Mehrotra R; Naicker S; Pecoits-Filho R; Perl J; Wang AY; Wilkie M; Howell M; Sautenet B; Evangelidis N; Shen JI; Johnson DW;
    Perit Dial Int; 2017; 37(6):639-647. PubMed ID: 28765167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review.
    Sautenet B; Cho Y; Gutman T; Rangan G; Ong A; Chapman AB; Ahn C; Coolican H; Tze-Wah Kao J; Fowler K; Gansevoort RT; Geneste C; Perrone RD; Harris T; Torres VE; Pei Y; Craig JC; Tong A;
    Am J Kidney Dis; 2020 Aug; 76(2):213-223. PubMed ID: 32171640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
    Smith KA; Thompson AM; Baron DA; Broadbent ST; Lundstrom GH; Perrone RD
    Am J Kidney Dis; 2019 Apr; 73(4):533-541. PubMed ID: 30600104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.
    Tong A; Tunnicliffe DJ; Lopez-Vargas P; Mallett A; Patel C; Savige J; Campbell K; Patel M; Tchan MC; Alexander SI; Lee V; Craig JC; Fassett R; Rangan GK
    Nephrology (Carlton); 2016 Feb; 21(2):122-32. PubMed ID: 26235729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.
    Tong A; Manns B; Wang AYM; Hemmelgarn B; Wheeler DC; Gill J; Tugwell P; Pecoits-Filho R; Crowe S; Harris T; Van Biesen W; Winkelmayer WC; Levin A; Thompson A; Perkovic V; Ju A; Gutman T; Bernier-Jean A; Viecelli AK; O'Lone E; Shen J; Josephson MA; Cho Y; Johnson DW; Sautenet B; Tonelli M; Craig JC;
    Kidney Int; 2018 Dec; 94(6):1053-1068. PubMed ID: 30360959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.
    Cho Y; Sautenet B; Gutman T; Rangan G; Craig JC; Ong AC; Chapman A; Ahn C; Coolican H; Kao JT; Gansevoort R; Perrone RD; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Johnson DW; Viecelli AK; Geneste C; Kim H; Kim Y; Oh YK; Teixeira-Pinto A; Logeman C; Howell M; Ju A; Manera KE; Tong A
    Nephrology (Carlton); 2019 Dec; 24(12):1214-1224. PubMed ID: 30663163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
    Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
    Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardising the reporting of outcomes in gastric cancer surgery trials: protocol for the development of a core outcome set and accompanying outcome measurement instrument set (the GASTROS study).
    Alkhaffaf B; Glenny AM; Blazeby JM; Williamson P; Bruce IA
    Trials; 2017 Aug; 18(1):370. PubMed ID: 28793921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing Consensus-Based Outcome Domains for Trials in Children and Adolescents With CKD: An International Delphi Survey.
    Logeman C; Guha C; Howell M; Hanson CS; Craig JC; Samuel S; Zappitelli M; Matsuda-Abedini M; Dart A; Furth S; Eddy A; Groothoff J; Yap HK; Bockenhauer D; Sinha A; Alexander SI; Goldstein SL; Gipson DS; Michael M; Walker A; Kausman J; Gaillard S; Bacchetta J; Rheault MN; Warady BA; Neu A; Christian M; McTaggart S; Liu I; Teo S; Sautenet B; Gutman T; Carter S; Teixeira-Pinto A; Tong A
    Am J Kidney Dis; 2020 Oct; 76(4):533-545. PubMed ID: 32654889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
    Perrone RD; Neville J; Chapman AB; Gitomer BY; Miskulin DC; Torres VE; Czerwiec FS; Dennis E; Kisler B; Kopko S; Krasa HB; LeRoy E; Castedo J; Schrier RW; Broadbent S
    Am J Kidney Dis; 2015 Oct; 66(4):583-90. PubMed ID: 26088508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies.
    Khalil A; Duffy JMN; Perry H; Ganzevoort W; Reed K; Baschat AA; Deprest J; Gratacos E; Hecher K; Lewi L; Lopriore E; Oepkes D; Papageorghiou A; Gordijn SJ;
    Trials; 2019 Jan; 20(1):35. PubMed ID: 30626413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology-Kidney Transplantation Consensus Workshops.
    Tong A; Gill J; Budde K; Marson L; Reese PP; Rosenbloom D; Rostaing L; Wong G; Josephson MA; Pruett TL; Warrens AN; Craig JC; Sautenet B; Evangelidis N; Ralph AF; Hanson CS; Shen JI; Howard K; Meyer K; Perrone RD; Weiner DE; Fung S; Ma MKM; Rose C; Ryan J; Chen LX; Howell M; Larkins N; Kim S; Thangaraju S; Ju A; Chapman JR;
    Transplantation; 2017 Aug; 101(8):1887-1896. PubMed ID: 28737661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.